PlainRecalls
FDA Drug Moderate Class II Ongoing

Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

Reported: January 14, 2026 Initiated: December 18, 2025 #D-0249-2026

Product Description

Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

Reason for Recall

Presence of particulate matter - Glass like particles.

Details

Recalling Firm
Imprimis NJOF, LLC
Units Affected
778 boxes of 15,540 pre-filled syringes
Distribution
U.S Nationwide
Location
Ledgewood, NJ

Frequently Asked Questions

What product was recalled?
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1. Recalled by Imprimis NJOF, LLC. Units affected: 778 boxes of 15,540 pre-filled syringes.
Why was this product recalled?
Presence of particulate matter - Glass like particles.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 14, 2026. Severity: Moderate. Recall number: D-0249-2026.